Cargando…

Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis

BACKGROUND: Immunotherapy has been shown to reduce relapses in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder (MOG-AD); however, the superiority of specific treatments remains unclear. AIM: To identify the efficacy and tolerability of different treatments for MOG-AD....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaofei, Kong, Lingyao, Zhao, Zhengyang, Shi, Ziyan, Chen, Hongxi, Lang, Yanlin, Lin, Xue, Du, Qin, Zhou, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360318/ https://www.ncbi.nlm.nih.gov/pubmed/35958613 http://dx.doi.org/10.3389/fimmu.2022.953993

Ejemplares similares

The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases
por: Wang, Xiaofei, et al.
Publicado: (2022)

Visual disability in neuromyelitis optica spectrum disorders: prognostic prediction models
por: Luo, Wenqin, et al.
Publicado: (2023)

The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab
por: Zhang, Rui, et al.
Publicado: (2023)

Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study
por: Lang, Yanlin, et al.
Publicado: (2023)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders
por: Shi, Ziyan, et al.
Publicado: (2022)

Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry
por: Marchionatti, Amanda, et al.
Publicado: (2021)

Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

HLA association in MOG-IgG– and AQP4-IgG–related disorders of the CNS in the Dutch population
por: Bruijstens, Arlette L., et al.
Publicado: (2020)

Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
por: Kong, Lingyao, et al.
Publicado: (2022)

Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
por: Kong, Lingyao, et al.
Publicado: (2022)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
por: Brill, Livnat, et al.
Publicado: (2021)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
por: Bollo, Luca, et al.
Publicado: (2021)

Effects of pregnancy on neuromyelitis optica spectrum disorder and predictors of related attacks
por: Du, Qin, et al.
Publicado: (2022)

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
por: Saadoun, Samira, et al.
Publicado: (2014)

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka
por: Senanayake, Bimsara, et al.
Publicado: (2019)

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
por: Fadda, Giulia, et al.
Publicado: (2022)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
por: Manzano, Giovanna S., et al.
Publicado: (2022)

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
por: Pache, Florence, et al.
Publicado: (2016)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient
por: Mohseni, Seyed Hamidreza, et al.
Publicado: (2018)

Optic neuritis of MOG-IgG-associated autoimmune disorders: a case report
por: Li, Tiantian, et al.
Publicado: (2021)

Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG
por: Ji, Suqiong, et al.
Publicado: (2021)

Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study
por: Cai, Linjun, et al.
Publicado: (2022)

The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains
por: de Haan, Noortje, et al.
Publicado: (2017)

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison
por: Narongkhananukul, Chanomporn, et al.
Publicado: (2020)

Epitope-Specific Suppression of IgG Responses by Passively Administered Specific IgG: Evidence of Epitope Masking
por: Bergström, Joakim J. E., et al.
Publicado: (2017)

Myocardial Injury in Hospitalized Patients with Myasthenia Gravis
por: Chen, Hongxi, et al.
Publicado: (2022)

Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men
por: Pillay, Thevani, et al.
Publicado: (2019)

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2017)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)

Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations in vivo
por: Schaffert, Anja, et al.
Publicado: (2020)

C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors in vitro
por: Temming, A. Robin, et al.
Publicado: (2021)

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
por: Hofrichter, Maxi, et al.
Publicado: (2018)

What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients
por: Hamid, Shahd H. M., et al.
Publicado: (2017)

Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder
por: Luo, Wenqin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ct44m9q2q31h9i3rq89l8r0fe2